MAPAX
Price
$31.01
Change
+$0.16 (+0.52%)
Updated
Jul 3 closing price
Net Assets
957.35M
VIVIX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

MAPAX vs VIVIX

Header iconMAPAX vs VIVIX Comparison
Open Charts MAPAX vs VIVIXBanner chart's image
NYLI WMC Value
Price$31.01
Change+$0.16 (+0.52%)
VolumeN/A
Net Assets957.35M
Vanguard Value Index I
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
MAPAX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MAPAX vs. VIVIX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MAPAX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 189B vs. MAPAX (957M). VIVIX pays higher dividends than MAPAX: VIVIX (2.19) vs MAPAX (1.39). MAPAX was incepted earlier than VIVIX: MAPAX (26 years) vs VIVIX (27 years). MAPAX (1.02) is less costly to investors than VIVIX (0.04). MAPAX is a more actively managed with annual turnover of: 38.00 vs. VIVIX (9.00). MAPAX has a lower initial minimum investment than VIVIX: MAPAX (15000) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 12.05 vs. MAPAX (8.49). VIVIX return over 5 years is better than : 80.14 vs. MAPAX (-13.45).
MAPAXVIVIXMAPAX / VIVIX
Total Expense Ratio1.020.042,550%
Annual Report Gross Expense Ratio1.020.042,550%
Fund Existence26 years27 years-
Gain YTD5.8006.21593%
Front Load6%N/A-
Min. Initial Investment1500050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets957M189B1%
Annual Yield % from dividends1.392.1963%
Returns for 1 year8.4912.0570%
Returns for 3 years19.7135.1756%
Returns for 5 years-13.4580.14-17%
Returns for 10 years-25.46115.68-22%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KB85.701.60
+1.90%
KB Financial Group
EVER24.530.34
+1.41%
EverQuote
FBP21.930.26
+1.20%
First BanCorp
SGMO0.53-0.01
-1.51%
Sangamo Therapeutics
SNSE9.03-0.24
-2.54%
Sensei Biotherapeutics Inc